http://archive.fast-edgar.com/20240418/AE2QM222ZZ22Q22S229K2W42D6GHZK22Z262
Filed on: April 18, 2024
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
Bicycle Therapeutics plc
(Name of Issuer)
Ordinary Shares, nominal value £0.01 per share
(Title of Class of Securities)
088786108**
(CUSIP number)
Alexandra A. Toohey
Chief Financial Officer
Baker Bros. Advisors LP
860 Washington Street, 3rd Floor
New York, NY 10014
(212)... (continue reading...)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE TO
TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934
AMENDMENT NO. 3
GEOPARK LIMITED
(Name of Subject Company (Issuer) and Filing Person (Offeror))
COMMON SHARES, PAR VALUE U.S.$0.001 PER SHARE
(Title of Class of Securities)
G38327105
(CUSIP Number of Class of Securities)
Mónica Jiménez... (continue reading...)
More SEC Filings
View Older Stories-
Form CERT CDT Environmental Techno
-
Form 6-K TAIWAN SEMICONDUCTOR For: Apr 18
-
Form 3 BICYCLE THERAPEUTICS For: Apr 18 Filed by: 667, L.P.
-
Form CERT Mingteng International
-
Form 13F-NT HSBC International Trust For: Mar 31
-
Form 497K Tidal Trust II
-
Form 6-K Lion Electric Co For: Apr 18
-
Form 6-K TAIWAN SEMICONDUCTOR For: Dec 31
-
Form 497VPSUB NATIONWIDE VARIABLE ACCO
-
Form DEFA14A Compass, Inc.
-
Form 6-K ECOPETROL S.A. For: Jun 30
-
Form 8-K GREENLIGHT CAPITAL RE, For: Apr 12
-
Form DEF 14A Compass, Inc. For: Apr 18
-
Form 8-K MARSH & MCLENNAN COMPANI For: Apr 18
-
Form 6-K Argo Blockchain Plc For: Apr 18
-
Form ARS Brighthouse Financial, For: Dec 31
-
Form 6-K Mobilicom Ltd For: Apr 18
-
Form DEFA14A Brighthouse Financial,
-
Form DEFA14A BICYCLE THERAPEUTICS
-
Form 10-Q Iridium Communications For: Mar 31
-
Form 20-F JD.com, Inc. For: Dec 31
-
Form 8-K Vertex Energy Inc. For: Apr 18
-
Form DEF 14A Brighthouse Financial, For: Jun 06
-
Form POS AM RedHill Biopharma Ltd.
-
Form 8-K Mawson Infrastructure For: Apr 18
-
Form 8-K Allarity Therapeutics, For: Apr 17
-
Form 8-K BICYCLE THERAPEUTICS For: Apr 16
-
Form 6-K Tiziana Life Sciences For: Apr 18
-
Form 8-K Iridium Communications For: Apr 18
-
Form 8-K NEOGENOMICS INC For: Apr 15
-
Form 8-K Blackstone Inc. For: Apr 18
-
Form 6-K SHINHAN FINANCIAL GROUP For: Apr 18
-
Form 6-K ENDEAVOUR SILVER CORP For: Apr 18
-
Form NPORT-P BNY Mellon Alcentra Glob For: Feb 29
-
Form NPORT-P BNY Mellon Investment For: Feb 29
-
Form NPORT-P BNY MELLON STRATEGIC For: Feb 29
-
Form NPORT-P BNY Mellon Investment For: Feb 29
-
Form NPORT-P BNY MELLON NEW YORK AMT- For: Feb 29
-
Form 144 VivoPower International Filed by: AWN HOLDINGS Ltd
-
Form NPORT-P BNY Mellon Strategic For: Feb 29
-
Form 6-K Baozun Inc. For: Apr 18
-
Form NPORT-P BNY Mellon Strategic For: Feb 29
-
Form NPORT-P BNY Mellon Strategic For: Feb 29
-
Form NPORT-P BNY Mellon Strategic For: Feb 29
-
Form 13F-HR Waterway Wealth Manageme For: Mar 31
-
Form NPORT-P BNY MELLON FUNDS TRUST For: Feb 29
-
Form NPORT-P BNY MELLON FUNDS TRUST For: Feb 29
-
Form 8-K Mirion Technologies, For: Apr 18
-
Form NPORT-P BNY MELLON FUNDS TRUST For: Feb 29
-
Form NPORT-P BNY MELLON FUNDS TRUST For: Feb 29